- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03029559
Intermittent Hypoxia and Inspiratory Threshold Loading to Enhance Inspiratory Muscle Function
Intermittent Hypoxia and Inspiratory Threshold Loading as Strategies to Enhance Inspiratory Muscle Function
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Investigators will test whether exposure to IH alone and in combination with inspiratory threshold loading (ITL) will result in increased inspiratory muscle strength and ventilation.
Investigators will use a Latin square, repeated measures design which will consist of 12 subjects participating in four experimental conditions.There will be an interval of 1 week between each of the four conditions, which will serve as a washout period.
At the end of each of the 5 sessions, the subjects will rest in a reclining chair for 15 minutes while their heart rate, blood pressure, oxygen saturation and breathing are monitored. Subjects that have a blood systolic blood pressure > 140 or diastolic pressure > 90 or SPO2 < 92% will be asked to remain in the laboratory for 15 additional minutes and the vital signs will be repeated. If the blood pressure and/or peripheral capillary oxygen saturation (SPO2) remain outside of the criteria mentioned above, the subject will be instructed to seek assessment by their health provider and the incident will be reported to the Institutional Review Board. Subjects will also be asked to report any discomfort.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- University of Florida
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participating in three or fewer musculoskeletal strength training sessions per week at an intensity equivalent to 7-10 on the Modified Borg's scale
- Participating in three or fewer cardiovascular endurance training sessions per week at an intensity equivalent to 7-10 on the Modified Borg's scale
Exclusion Criteria:
- Diagnosis of cardiovascular disease (Hypertension, arrhythmias, coronary artery disease, congenital and valvar heart diseases)
- Diagnosis of neuromuscular disease
- Diagnosis of any neurological disease
- Presence of concurrent medical illness including infection, fractures
- Diagnosis of obstructive sleep apnea
- Diagnosis of obstructive/restrictive lung disease
- Diagnosis of exercise induced asthma
- Forced expiratory volume at one second/forced vital capacity (FVC) <80% and/or FVC<80% of predicted value indicating airway obstruction
- Subjects on prednisolone therapy or selective serotonin reuptake inhibitor (SSRI) therapy will be excluded from the study.
- Diagnosis of epilepsy or history of seizures and attention deficit disorders
- Pregnancy
- Diabetes
- History of coagulation disorders
- History of chronic pain
- Body mass index(BMI)> 35kg/m2
- Subjects on prescription medicines such as beta blockers and other drugs that are prescribed in any of the exclusionary disorders listed above.
- Any other factor that in the investigators' opinions would prevent response to training or create an unsafe condition for the subject.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: IH + ITL
Subjects will be exposed to a session of Intermittent hypoxia (IH) (45 minutes, 2 minutes of hypoxia alternating with 1 minute of hyperoxia) followed by 5 sets of Inspiratory threshold loading (ITL) at 80%MIP (10 breaths per set).
|
A single session of IH will last for 45 minutes and will consist of alternating phases of hypoxia(FiO2 :9%-11%) and hyperoxia (FiO2 :22%-38%). Each hypoxic interval will last for 2 minutes whereas the hyperoxic interval lasts for 1 minute each (15, two-minute episodes of hypoxia and 15, one-minute episodes of hyperoxia).
Other Names:
Subjects will undergo inspiratory threshold loading using a commercially available Threshold IMT device (Power breathe®).
ITL will be administered at an intensity of 80% of the individual's maximal inspiratory pressure (MIP).
The subjects will be instructed to take 10 deep, forceful breaths through the threshold device followed by at least 2 minutes of rest.
The process will be repeated 4 more times for a total of 5 sets of 10 breaths each.
Other Names:
|
EXPERIMENTAL: Intermittent hypoxia (IH)
Subjects will only be exposed to a session of intermittent hypoxia.
|
A single session of IH will last for 45 minutes and will consist of alternating phases of hypoxia(FiO2 :9%-11%) and hyperoxia (FiO2 :22%-38%). Each hypoxic interval will last for 2 minutes whereas the hyperoxic interval lasts for 1 minute each (15, two-minute episodes of hypoxia and 15, one-minute episodes of hyperoxia).
Other Names:
|
EXPERIMENTAL: Sham IH + ITL
Sham Intermittent Hypoxia + Inspiratory threshold loading (ITL) subjects will be exposed to a single 45-minute session of sham IH (normoxia).
This will consist of the subject breathing room air (FiO2=21%) through a 4 way valve connected to the hypoxicator.
Exposure to normoxia will be followed by 5 sets of ITL at 80%MIP (10 breaths per set).
|
Subjects will undergo inspiratory threshold loading using a commercially available Threshold IMT device (Power breathe®).
ITL will be administered at an intensity of 80% of the individual's maximal inspiratory pressure (MIP).
The subjects will be instructed to take 10 deep, forceful breaths through the threshold device followed by at least 2 minutes of rest.
The process will be repeated 4 more times for a total of 5 sets of 10 breaths each.
Other Names:
Subjects will be exposed to a session of sham Intermittent hypoxia.This will consist of breathing room air for 45 minutes through a hypoxicator.
Other Names:
|
SHAM_COMPARATOR: Sham IH
Sham intermittent hypoxia subjects will be exposed to a single 45-minute session of sham IH alone.
|
Subjects will be exposed to a session of sham Intermittent hypoxia.This will consist of breathing room air for 45 minutes through a hypoxicator.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal Inspiratory Pressure will be measured across all groups
Time Frame: Change between 15, 30, and 60 minutes
|
Maximal Inspiratory Pressure(MIP) which is a measure of inspiratory muscle strength will be measured as the MIP recorded at the mouth by a pressure manometer.
Subjects will be seated upright in a comfortable chair and the nose occluded with clips.
After exhaling to residual volume (RV), subjects place their lips around the mouthpiece and inspire as forcefully as possible for at least three seconds.
Repeated measurements will be taken, with a 1- to 2-min rest between trials, until three measurements are obtained within 5% variability.
Of these three values, the best MIP will be recorded.
|
Change between 15, 30, and 60 minutes
|
Ventilatory responses to inspiratory loading will be measured across all groups
Time Frame: Change between 15, 30, and 60 minutes
|
Subjects will be asked to breathe as forcefully as possible against a inspiratory load( 2-4 sets of 5 repetitions) of either 40% of their maximal inspiratory pressure(MIP) or at 41CmH2O (lowest of the two as the maximum resistance offered by the device is 41CmH2O) using a inspiratory muscle training (IMT) device.
During this task, a respiratory monitor will be connected to the IMT device.
Parameters such as the inspiratory flow, volume and pressure generated by the subjects while breathing against the load will be recorded.
Imposed work of breathing (WOBi) will be calculated as a product of the pressure generated and the inspired tidal volume when breathing against a fixed load (40%MIP).
|
Change between 15, 30, and 60 minutes
|
Mouth occlusion pressure (P0.1) will be measured across all groups
Time Frame: Change between 15, 30, and 60 minutes
|
To record P0.1, the subjects will breathe through a mouth piece connected to a 2 way respiratory valve in a closed circuit. As the subjects breathe through the circuit, the inspiratory valve will be manually occluded during the expiratory phase and the occlusion will be maintained till the end of next inspiration. Occlusion will be random in order to prevent the subjects from getting conscious about the occlusions. The circuit is connected to the respiratory monitor and the negative pressure recorded in the first 100 milliseconds of the occluded breath will be recorded as the subject's P0.1. 3 such recordings will be obtained and the highest pressure amongst the 3 trials will be considered for analysis. |
Change between 15, 30, and 60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart Rate Variability (HRV) will be measured across all groups
Time Frame: Change between 15, 30, and 60 minutes
|
Heart Rate Variability (HRV): HRV will be assessed to determine the autonomic response to intermittent hypoxia.
HRV will be measured using a 3 lead ECG and HRV recording kit.
|
Change between 15, 30, and 60 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel Martin, PhD, University of Florida
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201601878
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intermittent Hypoxia
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
Robert L. OwensCompletedIntermittent HypoxiaUnited States
-
University of Texas at AustinCompleted
-
Children's National Research InstituteBoston University; Eunice Kennedy Shriver National Institute of Child Health... and other collaboratorsCompleted
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
University of UlmUnknownApnea of Prematurity | Intermittent HypoxemiaGermany
-
Istanbul Training and Research HospitalCompleted
-
Imperial College LondonCompletedIntermittent Pneumatic CompressionUnited Kingdom
-
BBraun Medical SASCompletedIntermittent Urethral CatheterizationFrance
-
Wellspect HealthCareCompletedIntermittent Urethral CatheterizationAustralia, United States
Clinical Trials on Intermittent Hypoxia
-
Capital Medical UniversityRecruiting
-
University of Colorado, BoulderMedical University of South Carolina; University of Colorado, Denver; Eunice...Enrolling by invitationIncomplete Spinal Cord InjuryUnited States
-
Northwestern UniversityRecruitingHealthy Brain PerfusionUnited States
-
Shirley Ryan AbilityLabUnknownSpinal Cord InjuriesUnited States
-
Shirley Ryan AbilityLabEnrolling by invitation
-
Indiana UniversityRehabilitation Hospital of IndianaRecruitingBrain InjuriesUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis-Relapsing-RemittingUnited States
-
Shirley Ryan AbilityLabEdward Hines Jr. VA HospitalCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States